IE58997B1 - Process and intermediates for beta-lactam antibiotics - Google Patents
Process and intermediates for beta-lactam antibioticsInfo
- Publication number
- IE58997B1 IE58997B1 IE190086A IE190086A IE58997B1 IE 58997 B1 IE58997 B1 IE 58997B1 IE 190086 A IE190086 A IE 190086A IE 190086 A IE190086 A IE 190086A IE 58997 B1 IE58997 B1 IE 58997B1
- Authority
- IE
- Ireland
- Prior art keywords
- formula
- acid
- ester
- group
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/755,982 US4665171A (en) | 1985-07-17 | 1985-07-17 | Process and intermediates for β-lactam antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
IE861900L IE861900L (en) | 1987-01-17 |
IE58997B1 true IE58997B1 (en) | 1993-12-15 |
Family
ID=25041514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE190086A IE58997B1 (en) | 1985-07-17 | 1986-07-16 | Process and intermediates for beta-lactam antibiotics |
Country Status (22)
Country | Link |
---|---|
US (1) | US4665171A (da) |
EP (2) | EP0209352B1 (da) |
JP (2) | JPH0762015B2 (da) |
KR (1) | KR900005257B1 (da) |
CN (1) | CN1015178B (da) |
AR (1) | AR243186A1 (da) |
AT (2) | ATE63118T1 (da) |
AU (2) | AU595216B2 (da) |
CA (1) | CA1310323C (da) |
DE (2) | DE3650474T2 (da) |
DK (2) | DK173456B1 (da) |
ES (2) | ES2000516A6 (da) |
GR (1) | GR861857B (da) |
HK (1) | HK1007140A1 (da) |
HU (2) | HU906465D0 (da) |
IE (1) | IE58997B1 (da) |
IL (1) | IL79420A (da) |
NZ (1) | NZ216871A (da) |
PT (1) | PT82989B (da) |
RU (1) | RU1794079C (da) |
SU (1) | SU1579460A3 (da) |
ZA (1) | ZA865274B (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870169A (en) * | 1985-07-17 | 1989-09-26 | President And Fellows Of Harvard College | Intermediates for beta-lactam antibiotics |
US4673737A (en) * | 1985-08-02 | 1987-06-16 | Harvard University | 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof |
US4734498A (en) * | 1986-07-10 | 1988-03-29 | Eli Lilly And Company | 3β-succinimidoazetidinones as chiral intermediates |
CA1323370C (en) * | 1986-09-12 | 1993-10-19 | Davis H. Crater | Fluorochemical oxazolidinones |
US4782144A (en) * | 1987-09-14 | 1988-11-01 | Eli Lilly And Company | 1-carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof |
US5019571A (en) * | 1988-01-25 | 1991-05-28 | Eli Lilly And Company | 1-carbacephalosporin antibiotics |
US4820832A (en) * | 1988-03-23 | 1989-04-11 | Eli Lilly And Company | Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins |
US4855418A (en) | 1988-03-23 | 1989-08-08 | Eli Lilly And Company | Process for production of ceophalosporins |
EP0345998A1 (en) * | 1988-06-06 | 1989-12-13 | Eli Lilly And Company | Process and intermediates for beta-lactam antibiotics |
EP0345999A1 (en) * | 1988-06-06 | 1989-12-13 | Eli Lilly And Company | Process for intermediates to 1-carba(1-dethia)-3-cephem-4-carboxylic acids |
US4885362A (en) * | 1988-06-06 | 1989-12-05 | Eli Lilly And Company | Azetidinone intermediates for 1-carba(dethia)caphalosporins |
DE68914888T2 (de) * | 1988-06-22 | 1994-09-15 | Lilly Co Eli | Zwischenprodukt für 1-Carba(dethia)cephalosporin. |
KR0169096B1 (ko) * | 1988-10-11 | 1999-01-15 | 리로이 휘테커 | 카바세팔로스포린의 아제티디논 중간체 화합물 및 제조방법 |
US5453503A (en) * | 1988-10-11 | 1995-09-26 | Eli Lilly And Company | Azetidinone intermediates to carbacephalosporins and process |
US4931557A (en) * | 1988-10-17 | 1990-06-05 | Eli Lilly And Company | Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof |
US4931556A (en) * | 1988-10-17 | 1990-06-05 | Eli Lilly And Company | Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-methoxycarbonylmethyl-azetidin-2-one and malic acid salts thereof |
JPH02252648A (ja) * | 1989-03-27 | 1990-10-11 | Naomi Iwagou | イオン溶出燒結体 |
US5106475A (en) * | 1989-09-20 | 1992-04-21 | Eli Lilly And Company | Process for preparing 4-substituted azetidinones |
US4992545A (en) * | 1989-09-20 | 1991-02-12 | Eli Lilly And Company | Process for preparing 4-substituted azetidinones |
US5030725A (en) * | 1990-02-06 | 1991-07-09 | Eli Lilly And Company | Method of resolving cis 3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one using (-)-DAG |
US5051502A (en) * | 1990-06-06 | 1991-09-24 | University Of Notre Dame Du Lac | Rhodium catalyzed cyclization process for bicyclic β-lactams |
EP0479431B1 (en) * | 1990-09-13 | 1999-12-08 | Eli Lilly And Company | Intermediates to 1-carbacephalosporins and process for preparation thereof |
US5089610A (en) * | 1991-04-25 | 1992-02-18 | Eli Lilly And Company | Ring-closure method for 1-carbacephalosporin six-membered ring |
US5521307A (en) * | 1992-02-18 | 1996-05-28 | Eli Lilly And Company | Methods and compounds for the preparation of carbacephems |
ATE305781T1 (de) | 1996-02-23 | 2005-10-15 | Lilly Co Eli | Non-peptidische vasopressin via antagonisten |
JP2002535680A (ja) | 1999-01-27 | 2002-10-22 | ファルマシア・アンド・アップジョン・カンパニー | 延長因子p活性モジュレーターのアッセイ方法 |
JP4916929B2 (ja) * | 2007-03-23 | 2012-04-18 | ヤマハ発動機株式会社 | 直交型ロボット |
WO2009049238A1 (en) | 2007-10-11 | 2009-04-16 | The Regents Of The University Of California | Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase |
US9376424B2 (en) | 2010-07-01 | 2016-06-28 | Azevan Pharmaceuticals, Inc. | Methods for treating post traumatic stress disorder |
WO2014144836A2 (en) * | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors |
WO2014144547A2 (en) | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors |
JP7255967B2 (ja) | 2014-03-28 | 2023-04-11 | アゼヴァン ファーマスーティカルズ,インコーポレイテッド | 神経変性疾患を治療するための組成物および方法 |
US20190321363A1 (en) * | 2016-06-20 | 2019-10-24 | Dr. Reddy's Laboratories Limited | Process for the preparation of elagolix sodium and its polymorph |
CN112500361B (zh) * | 2020-12-27 | 2023-05-12 | 甘肃瀚聚药业有限公司 | 一种(s)-4-苯基-2-恶唑烷酮的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4226866A (en) * | 1972-11-06 | 1980-10-07 | Merck & Co., Inc. | Novel antibiotic analogues of cephalosporins |
US4166816A (en) * | 1975-05-05 | 1979-09-04 | Smithkline Corporation | Methods and intermediates for preparing cis-4-oxoazetidine intermediates |
US4200572A (en) * | 1975-09-03 | 1980-04-29 | Smithkline Corporation | Substituted azetidinones |
ZA766941B (en) * | 1975-11-21 | 1978-06-28 | Merck & Co Inc | 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof |
US4174316A (en) * | 1978-08-14 | 1979-11-13 | Merck & Co., Inc. | 4-Iodomethylazetidin-2-one |
US4472576A (en) * | 1982-12-03 | 1984-09-18 | Merck & Co., Inc. | Processes for the production of antibiotic 1-oxadethiacephalosporins |
US4502994A (en) | 1982-12-09 | 1985-03-05 | Hoffmann-La Roche Inc. | Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate |
US4751299A (en) * | 1983-11-18 | 1988-06-14 | Takeda Chemical Industries, Ltd. | Optically active β-lactams and method of their production |
US4673737A (en) | 1985-08-02 | 1987-06-16 | Harvard University | 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof |
-
1985
- 1985-07-17 US US06/755,982 patent/US4665171A/en not_active Expired - Fee Related
-
1986
- 1986-07-15 IL IL79420A patent/IL79420A/xx not_active IP Right Cessation
- 1986-07-15 HU HU906465A patent/HU906465D0/hu unknown
- 1986-07-15 ZA ZA865274A patent/ZA865274B/xx unknown
- 1986-07-15 PT PT82989A patent/PT82989B/pt not_active IP Right Cessation
- 1986-07-15 EP EP86305424A patent/EP0209352B1/en not_active Expired - Lifetime
- 1986-07-15 AT AT86305424T patent/ATE63118T1/de not_active IP Right Cessation
- 1986-07-15 DK DK198603356A patent/DK173456B1/da not_active IP Right Cessation
- 1986-07-15 AU AU60166/86A patent/AU595216B2/en not_active Expired
- 1986-07-15 HU HU862911A patent/HU201931B/hu not_active IP Right Cessation
- 1986-07-15 DE DE3650474T patent/DE3650474T2/de not_active Expired - Fee Related
- 1986-07-15 DE DE8686305424T patent/DE3679002D1/de not_active Expired - Lifetime
- 1986-07-15 RU SU864027832A patent/RU1794079C/ru active
- 1986-07-15 EP EP89120951A patent/EP0362902B1/en not_active Expired - Lifetime
- 1986-07-15 AT AT89120951T patent/ATE133172T1/de not_active IP Right Cessation
- 1986-07-16 KR KR1019860005753A patent/KR900005257B1/ko not_active IP Right Cessation
- 1986-07-16 ES ES8600341A patent/ES2000516A6/es not_active Expired
- 1986-07-16 CA CA000513971A patent/CA1310323C/en not_active Expired - Lifetime
- 1986-07-16 JP JP61168982A patent/JPH0762015B2/ja not_active Expired - Lifetime
- 1986-07-16 CN CN86104783A patent/CN1015178B/zh not_active Expired
- 1986-07-16 GR GR861857A patent/GR861857B/el unknown
- 1986-07-16 IE IE190086A patent/IE58997B1/en not_active IP Right Cessation
- 1986-07-16 NZ NZ216871A patent/NZ216871A/xx unknown
- 1986-07-17 AR AR86304531A patent/AR243186A1/es active
-
1987
- 1987-06-05 SU SU874202676A patent/SU1579460A3/ru active
- 1987-12-31 ES ES8703788A patent/ES2005752A6/es not_active Expired
-
1990
- 1990-01-12 AU AU47934/90A patent/AU619938B2/en not_active Ceased
-
1994
- 1994-12-21 JP JP6318486A patent/JP2634775B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-15 DK DK016096A patent/DK16096A/da not_active Application Discontinuation
-
1998
- 1998-06-22 HK HK98105920A patent/HK1007140A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0209352B1 (en) | Process and intermediates for beta-lactam antibiotics | |
US5091525A (en) | Monohydrate and DMF solvates of a new carbacephem antibiotic | |
JP2529544B2 (ja) | 抗生物質のための中間体の製造方法 | |
KR950013767B1 (ko) | 키랄성 아제티디논 화합물 및 이의 제조방법 | |
EP0635488B1 (en) | Novel process for preparing azetidinone compound and novel starting compound therefor | |
KR100231223B1 (ko) | 아제티디논 화합물 및 이의 제조방법 | |
US4089956A (en) | 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof | |
US4870169A (en) | Intermediates for beta-lactam antibiotics | |
US4166816A (en) | Methods and intermediates for preparing cis-4-oxoazetidine intermediates | |
US4734495A (en) | Process and intermediates for beta-lactam antibiotics | |
JPS6143357B2 (da) | ||
US4775752A (en) | Process and intermediates for beta-lactam antibiotics | |
US4820816A (en) | 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics | |
CA1111856A (en) | Azetidinone derivatives and production thereof | |
CA1332059C (en) | Process for preparing cis-1-carba(1-dethia)cephalosporins and intermediates therefor | |
JPS63188662A (ja) | 新規なβ−ラクタム誘導体の製造方法 | |
KR900005322B1 (ko) | β-락탐 항생물질 제조용 중간체 | |
US4440682A (en) | Stereospecific synthesis of isocephalosporins and 2-oxa isocephalosporins | |
US4782144A (en) | 1-carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof | |
US5521307A (en) | Methods and compounds for the preparation of carbacephems | |
US4162250A (en) | 3-Aminoazetidinone derivatives | |
HU212104B (en) | Process for producing 3 beta-/4(s)-aryl-oxazolidine-2-one-3-il/-azetidine-2-one derivatives | |
US4778884A (en) | Process for 3-halo-1-carba(dethia)-3-cephem antibiotics | |
US4187375A (en) | Process for preparing oxazine ring compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |